Member Info for Mozax

And Furthermore, there are numerous examples of Companies who command stratospheric Valuations based on potential, well before and ‘serious’ revenues are made.

Well, watch out - Health insurance policies are big business throughout Corporate America, and Valuations will start to be extrapolated in due course……

Spartac.

Indeed. Sharebel looking in as he considers his trading strategy next week and trying to encourage a lower entry, Happy if it works as I want more too!!

The Trellus Platform has proved its value as it attracts one of the biggest Companies to fine tune its latest FDA approved drug “Tremfyd” in Trellus specialised field.

“This approval marks the fourth indication for TREMFYA® in the U.S., following moderate-to-severe plaque psoriasis in July 2017, active psoriatic arthritis in July 2020 and moderately to severely active UC in September 2024,6 underscoring Johnson & Johnson’s long-standing legacy in innovation and commitment to patients living with chronic immune-mediated diseases, including IBD. In November 2024, Johnson & Johnson submitted a supplemental Biologics License Application (sBLA) to the FDA seeking approval of a SC induction regimen of TREMFYA® for the treatment of adults with moderately to severely active UC, based on results of the Phase 3 ASTRO study.”

It’s interesting that this was submitted to the FDA in November 2024 and the pilot program with Trellus announced a few months later..momentum will start to build very soon…..

Spartacus - Excellent spot & Some good links.

This is getting very interesting with J&J’s FDA’s approval & tie up with Trellus!

Let’s see if the Market starts to pick up on this detail, and great spot of the 14p options.

Although I’ve bought a fair whack over the last few weeks I’ve made room in the ISA for more, so hopefully another buying opportunity next week before the market catches on.

Indeed Davey, our buyer can’t fill their £50K orders so now going through at £25K……

Let’s see what is printed after close…..

I’m presuming that the announcement from The Department of Health & Social Care of 13th March 2025

Announcing major reforms to drive efficiency at the NHS is behind this sudden interest.

With the seller out and some hefty institutional investors aboard for the long term we could see quite a re-rate here.

I note David & Monique Newlands hold 5.4%, over the years I note they are very capable stock pickers.

Indeed, well spotted - likely to be the same buyer chomping up the stock.

Clearly very oversold given the longevity of the business, future contracts and former valuations.

First buy of the day Kicked this off and now up 8% and L2 perked up.

Perhaps the seller is done and we can now focus on our £30 MILLION Value of CONTRACT Renewals as announced by RNS on 27th February 2025.

At the beginning of March 2025, so the Company is currently Valued at Cash in the bank.

There’s little point in raising funds now when they have cash reserves to last into November 2025, and a lot in the pipeline between now & then.

Personally, I believe a Company like J&J becoming involved isn’t just about the potential Revenue following their pilot, but it substantiates the technology enormously, and to attract the interest of such a behemoth is striking indeed. It further demonstrates that Trellus is here to stay, these programs are for rolling 12 month periods, so the Company is only going to grow.

My view is that further ‘commercial & strategic progress’ will be announced in due course, and due to the immensely low freefloat, the time to accumulate a good position is whilst it is off the radar, and weak holders are selling out at these attractive prices.

Anything under the current SP is less than cash, currently valuing the technology and business at Zero.

I will quietly continue to add.

We're running our XRP Power-Up Challenge. 🦸✨

Don't miss this chance to win a $1,000 worth of $XRP, all you need to do is to deposit or buy XRP on your Tap app.

Get the Tap app : tinyurl.com/Tap-today

T&Cs : tinyurl.com/xrpcamp

RNS - Trellus has been selected by Johnson & Johnson, a $400 Billion Company, the 5th Largest Company in the World by MCap.

“We are working hard to achieve further commercial and strategic progress and will provide further updates to the market in due course as appropriate."

Traders & Investors will be back around here pretty soon at these prices following the re-trace from over 5p after the J&J announcement.

They’ll want to take a position before the next announcement, and the clock is ticking.

And this moves very quickly with small volume.

That’s one hell of a drop, and going to cause a lot of holders a very stressful time.

The question is, do we believe GS?

Will they manage these deals ‘off market’ then re-list with a much bigger AUM and revenue?

If you believe then 0.3p is a steal, if you’re prepared to wait out the delisting and ‘hope’ it comes good.

I’m still waiting for another Company that de-listed in 2019 to re-list…….

Someone asked the ISA question, and very annoyingly, once delisted, the shares will be moved out of your ISA and to your trading account, where they will have zero value until the Company re-lists.

Cannot

Here today…….HL “Trade Connor proceed” on my fill or kill.

I’m overseas currently so am not going to call up HL, but it seems very odd, after 2 decent buys first thing no other trades have gone through, is this a TAP or Aquis problem?

Very odd trades today and volume 6m +…….

Try holding penny stocks, then you’ll know what a drop is.

A total overreaction.

RR buyback will go further at this price!! Perhaps they’ll step on it today.

@ Jaybike

Good Morning

You make an interesting point and it’s possible that some existing holders are starting to lock XTP hence increased trading Volumes.

Personally, I’m here for the long term, both as a Shareholder and XTP holder, I’ve locked XTP and will increase that over time to achieve higher cash-back rewards.

I do believe that TAP will make some significant improvements over the short/medium term and it’s going to be an interesting project.

A good podcast and communication from the Company, The Chairman & CEO bounce off one another well.

Huge amount of features and improvements coming, and I suspect When the TAP card can be loaded directly with GBP & USD combined with a US full launch users will increase dramatically.

Furthermore, I believe this will also be the turning point for XTP as more users will lock XTP for the various tiers of cash-back.

Lastly, It seems very clear that AT is extremely driven to build this Fintech ‘Super app’ and I personally believe he’s going to achieve something very exciting, along with this highly motivated team.

Great stuff, and we’ll done Peter, Ar5en and the team.

It would appear, …….hardly surprising when the retail investor is able to buy at a 30+% discount to the Institutional Investors…..,

Quite a bit of news-flow due here over the coming months.